Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
76.61 INR | -2.07% | -3.03% | -34.55% |
Valuation
Fiscal Period: March | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Capitalization 1 | 301.8 | 298.8 | 858.6 | 731.9 |
Enterprise Value (EV) 1 | 593.1 | 541.3 | 1,011 | 855.8 |
P/E ratio | 72.7 x | 158 x | 108 x | 80.8 x |
Yield | - | - | - | - |
Capitalization / Revenue | 0.32 x | 0.42 x | 0.91 x | 0.61 x |
EV / Revenue | 0.63 x | 0.77 x | 1.07 x | 0.71 x |
EV / EBITDA | 18.1 x | 13 x | 19.6 x | 22.7 x |
EV / FCF | -4.63 x | 9.87 x | 9.41 x | 31.4 x |
FCF Yield | -21.6% | 10.1% | 10.6% | 3.19% |
Price to Book | 1.17 x | 1.15 x | 3.22 x | 2.66 x |
Nbr of stocks (in thousands) | 7,545 | 7,545 | 7,545 | 7,545 |
Reference price 2 | 40.00 | 39.60 | 113.8 | 97.00 |
Announcement Date | 12/1/20 | 10/23/21 | 9/6/22 | 9/5/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 970.9 | 1,063 | 939.8 | 707 | 942.1 | 1,198 |
EBITDA 1 | 44.56 | 45.05 | 32.69 | 41.74 | 51.54 | 37.76 |
EBIT 1 | 43.98 | 44.53 | 32.37 | 41.4 | 51.17 | 36.66 |
Operating Margin | 4.53% | 4.19% | 3.44% | 5.86% | 5.43% | 3.06% |
Earnings before Tax (EBT) 1 | 15.33 | 8.857 | 4.224 | 2.789 | 11.05 | 14.11 |
Net income 1 | 10.34 | 6.259 | 3.148 | 1.899 | 7.967 | 9.054 |
Net margin | 1.06% | 0.59% | 0.33% | 0.27% | 0.85% | 0.76% |
EPS 2 | 3.090 | 1.167 | 0.5500 | 0.2500 | 1.056 | 1.200 |
Free Cash Flow 1 | -52.1 | -65.38 | -128.1 | 54.82 | 107.4 | 27.27 |
FCF margin | -5.37% | -6.15% | -13.63% | 7.75% | 11.4% | 2.28% |
FCF Conversion (EBITDA) | - | - | - | 131.35% | 208.33% | 72.21% |
FCF Conversion (Net income) | - | - | - | 2,887.27% | 1,347.8% | 301.19% |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 1/30/20 | 1/30/20 | 12/1/20 | 10/23/21 | 9/6/22 | 9/5/23 |
Balance Sheet Analysis
Fiscal Period: Marzo | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 201 | 267 | 291 | 242 | 152 | 124 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 4.52 x | 5.937 x | 8.91 x | 5.81 x | 2.952 x | 3.282 x |
Free Cash Flow 1 | -52.1 | -65.4 | -128 | 54.8 | 107 | 27.3 |
ROE (net income / shareholders' equity) | 13% | 5.49% | 1.57% | 0.74% | 3.03% | 3.34% |
ROA (Net income/ Total Assets) | 4.82% | 3.95% | 2.57% | 3.53% | 4.43% | 3.44% |
Assets 1 | 214.3 | 158.5 | 122.6 | 53.76 | 179.7 | 262.9 |
Book Value Per Share 2 | 25.30 | 26.80 | 34.00 | 34.30 | 35.40 | 36.40 |
Cash Flow per Share 2 | 1.660 | 0.8900 | 0.0700 | 3.210 | 7.610 | 8.530 |
Capex 1 | 0.16 | 0.06 | 0.04 | 0.2 | 1 | 3.69 |
Capex / Sales | 0.02% | 0.01% | 0% | 0.03% | 0.11% | 0.31% |
Announcement Date | 1/30/20 | 1/30/20 | 12/1/20 | 10/23/21 | 9/6/22 | 9/5/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-34.55% | 7.07M | |
+56.89% | 809B | |
+39.52% | 624B | |
-6.55% | 351B | |
+7.92% | 289B | |
+13.74% | 240B | |
+13.83% | 220B | |
-0.49% | 219B | |
+7.94% | 166B | |
-2.57% | 157B |
- Stock Market
- Equities
- CBPL Stock
- Financials Chandra Bhagat Pharma Limited